Yoshinori Iwatani Selected Research

Activated Protein C Resistance (APC Resistance)

5/2009	Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus.
3/2005	Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
11/2002	Acquired activated protein C resistance associated with anti-protein S antibody as a strong risk factor for DVT in non-SLE patients.
8/2002	Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Iwatani Research Topics

Disease

25	Thyroid Diseases (Thyroid Disease) 09/2023 - 09/2002
17	Graves Disease (Basedow Disease) 04/2024 - 04/2003
16	Hashimoto Disease (Thyroiditis, Hashimoto) 05/2020 - 09/2002
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2009 - 08/2002
4	Inflammation (Inflammations) 08/2017 - 10/2002
4	Infections 01/2015 - 01/2003
4	Activated Protein C Resistance (APC Resistance) 05/2009 - 08/2002
3	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 01/2016
3	Hypothyroidism 05/2009 - 09/2002
2	Carcinoma (Carcinomatosis) 04/2013 - 07/2009
2	Goiter 02/2013 - 12/2007
2	Hyperferritinemia 01/2009 - 10/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2006 - 11/2002
2	Venous Thromboembolism 03/2005 - 08/2002
2	Thrombosis (Thrombus) 03/2005 - 05/2004
1	Thyroiditis 11/2021
1	Bacteriuria 01/2019
1	Familial Mediterranean Fever (Periodic Disease) 01/2019
1	Vitiligo 01/2019
1	Pathologic Processes 04/2016
1	Cysts 10/2014
1	Immunoglobulin G4-Related Disease 10/2013
1	Fatty Liver 06/2013
1	Non-alcoholic Fatty Liver Disease 06/2013
1	Organophosphate Poisoning 02/2013
1	Thyroid Nodule (Nodule, Thyroid) 01/2012
1	Pre-Eclampsia (Preeclampsia) 07/2010
1	Neoplasms (Cancer) 07/2009
1	Iron Overload 01/2009
1	Stomach Neoplasms (Stomach Cancer) 11/2007
1	Thrombocytosis (Thrombocythemia) 01/2007

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2017 - 08/2002
6	Immunoglobulin G (IgG)IBA 10/2013 - 08/2002
6	Phospholipids (Phosphatides)FDA LinkGeneric 05/2009 - 08/2002
5	Interleukin-10 (Interleukin 10)IBA 04/2024 - 03/2004
5	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
4	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2013 - 09/2002
4	EnzymesIBA 01/2009 - 04/2003
4	Prothrombin (Factor II)IBA 05/2006 - 08/2002
3	MicroRNAs (MicroRNA)IBA 08/2017 - 04/2016
3	Messenger RNA (mRNA)IBA 04/2013 - 07/2009
3	thyrotropin-binding inhibitory immunoglobulinIBA 02/2013 - 06/2004
3	Interleukin-4 (Interleukin 4)IBA 05/2009 - 03/2004
3	PhosphatidylserinesIBA 05/2006 - 05/2004
3	Cardiolipins (Cardiolipin)IBA 05/2006 - 05/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2005 - 08/2002
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 03/2005 - 08/2002
2	AutoantibodiesIBA 01/2019 - 09/2002
2	Iodide Peroxidase (Deiodinase)IBA 07/2018 - 10/2017
2	InterleukinsIBA 08/2017 - 12/2007
2	CytokinesIBA 10/2013 - 03/2004
2	Protein SIBA 05/2009 - 11/2002
2	Ferritins (Ferritin)IBA 01/2009 - 10/2002
2	Immunoglobulins (Immunoglobulin)IBA 12/2007 - 04/2003
2	Antithyroid Agents (Antithyroid Drugs)IBA 12/2007 - 06/2004
2	Anti-Idiotypic AntibodiesIBA 05/2006 - 05/2004
2	factor V LeidenIBA 11/2002 - 08/2002
1	Histones (Histone)IBA 09/2023
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 11/2021
1	Vitamin A (Retinol)FDA LinkGeneric 11/2021
1	LigandsIBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Toll-Like Receptor 4IBA 01/2019
1	rhododendrolIBA 01/2019
1	Thyroglobulin FDA Link 09/2017
1	Interleukin-18 (Interleukin 18)IBA 07/2017
1	Interleukin-12 (IL 12)IBA 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Chemotactic FactorsIBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	NAD (NADH)IBA 01/2016
1	ChemokinesIBA 01/2016
1	Chemokine CCL5IBA 01/2016
1	Interleukin-16 (Interleukin 16)IBA 01/2016
1	Sirtuin 1IBA 01/2016
1	Hepatitis B Core AntigensIBA 01/2015
1	propamidineIBA 10/2014
1	Natamycin (Pimaricin)FDA Link 10/2014
1	Povidone-Iodine (Betadine)FDA LinkGeneric 10/2014
1	Ezetimibe (Zetia)FDA Link 06/2013
1	Dietary IronIBA 06/2013
1	Transaminases (Aminotransferases)IBA 06/2013
1	pralidoxime (Protopam Chloride)FDA Link 02/2013
1	SaltsIBA 02/2013
1	CreatinineIBA 07/2010
1	NestinIBA 07/2009
1	Differentiation AntigensIBA 07/2009
1	Long-Acting Thyroid Stimulator (LATS)IBA 05/2009
1	Transferrin (beta 2 Transferrin)IBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2007
1	SteroidsIBA 01/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2015